Open AccessPaclitaxel and carboplatin chemotherapy after platinum‑based chemotherapy and pembrolizumab for metastatic urothelial carcinoma
Author(s) -
Nobuki Furubayashi,
Yozo Hori,
Futoshi Morokuma,
Toshihisa Tomoda,
Takahito Negishi,
Tomohiro Inoue,
Masatoshi Kumagai,
Kentaro Kuroiwa,
Noriaki Tokuda,
Motonobu Nakamura
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2253
Subject(s) - pembrolizumab , medicine , carboplatin , chemotherapy , metastatic urothelial carcinoma , progressive disease , oncology , cancer , bladder cancer , urothelial carcinoma , cisplatin , immunotherapy